Global Ophthalmic Disease Therapeutics Market Size Study & Forecast, by Drug Class (Anti-inflammatory, Anti-invectives, Anti-VEGF and Others) by Dosage Form (Solid, Liquid and Semisolid), by Disease Indication (Glaucoma, Dry Eye Disease, Retinal Disease, Allergy & Infections and Others), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) and Regional Analysis, 2022-2029
Global Ophthalmic Disease Therapeutics Market is valued at approximately USD 31.54 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.4% over the forecast period 2022-2029. Drugs and therapies for treating various ocular ailments such as glaucoma, dry eye disease, retinal diseases, and others are included in ophthalmic disease therapeutics. The Ophthalmic Disease Therapeutics market is expanding because of factors such as the rising prevalence of ophthalmic conditions and increasing clinical trials and pipeline candidates for Innovative Drugs and Therapies.
Globally, the prevalence of ophthalmic diseases such as glaucoma, retinal diseases, dry eye disease, and others is on the rise which is catering for market growth. According to a 2020 article from the American Academy of Ophthalmology (AAO), 3.0 million Americans, of whom 2.7 million are 40 years of age or older, have glaucoma. According to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. The increasing number of initiatives taken by various healthcare organizations, governmental entities, and industry actors, there is a greater awareness among the public about ocular disorders, the market demand for treatments for ocular diseases is anticipated to be boosted by factors such as growing healthcare costs and an increase in the number of ophthalmologists in both developed and developing nations. According to the Welsh Government's 2021 report, The number of ophthalmic practitioners in Wales climbed to 961 in March 2021 from 885 in March 2020. However, the high cost of Ophthalmic Disease Therapeutics stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Ophthalmic Disease Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the increasing rates of diagnosis and treatment, as well as an increase in the prevalence of numerous ocular illnesses. Additionally, rising healthcare spending in the region supporting eye care and eye health, as well as acceptable compensation for a variety of ocular problems, encourage the region's major economies to adopt cutting-edge and novel treatments. Whereas Europe is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Viatris Inc.
Novartis AG
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceutical Co., Ltd.
Bayer AG
Bausch & Lomb Incorporated
Merck KGaA
Nicox SA
Recent Developments in the Market:
In May 2022, Zhaoke Ophthalmology Limited and Visus Therapeutics, Inc. partnership to commercialize BRIMOCHOL PF and Carbachol PF in Greater China, South Korea, and a few other Southeast Asian countries. Visus Therapeutics, Inc. specializes in the development of ophthalmic therapies. Both of these eye drops lack preservatives and are intended to correct presbyopia-related vision problems.
In March 2022, The European Commission has given Novartis AG clearance to market Beovu, an ophthalmic drug intended to treat diabetic macular edema-related vision loss.
Global Ophthalmic Disease Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Dosage Form, Disease Indication, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Classofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Anti-inflammatory
Anti-invectives
Anti-VEGF
Others
By Dosage Form:
Solid
Liquid
Semisolid
By Disease Indication:
Glaucoma
Dry Eye Disease
Retinal Disease
Allergy & Infections
Others
By Distribution Channel:
Hospital Pharmacies
Retail & Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Globally, the prevalence of ophthalmic diseases such as glaucoma, retinal diseases, dry eye disease, and others is on the rise which is catering for market growth. According to a 2020 article from the American Academy of Ophthalmology (AAO), 3.0 million Americans, of whom 2.7 million are 40 years of age or older, have glaucoma. According to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. The increasing number of initiatives taken by various healthcare organizations, governmental entities, and industry actors, there is a greater awareness among the public about ocular disorders, the market demand for treatments for ocular diseases is anticipated to be boosted by factors such as growing healthcare costs and an increase in the number of ophthalmologists in both developed and developing nations. According to the Welsh Government's 2021 report, The number of ophthalmic practitioners in Wales climbed to 961 in March 2021 from 885 in March 2020. However, the high cost of Ophthalmic Disease Therapeutics stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Ophthalmic Disease Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the increasing rates of diagnosis and treatment, as well as an increase in the prevalence of numerous ocular illnesses. Additionally, rising healthcare spending in the region supporting eye care and eye health, as well as acceptable compensation for a variety of ocular problems, encourage the region's major economies to adopt cutting-edge and novel treatments. Whereas Europe is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Viatris Inc.
Novartis AG
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceutical Co., Ltd.
Bayer AG
Bausch & Lomb Incorporated
Merck KGaA
Nicox SA
Recent Developments in the Market:
In May 2022, Zhaoke Ophthalmology Limited and Visus Therapeutics, Inc. partnership to commercialize BRIMOCHOL PF and Carbachol PF in Greater China, South Korea, and a few other Southeast Asian countries. Visus Therapeutics, Inc. specializes in the development of ophthalmic therapies. Both of these eye drops lack preservatives and are intended to correct presbyopia-related vision problems.
In March 2022, The European Commission has given Novartis AG clearance to market Beovu, an ophthalmic drug intended to treat diabetic macular edema-related vision loss.
Global Ophthalmic Disease Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Dosage Form, Disease Indication, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Classofferings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Anti-inflammatory
Anti-invectives
Anti-VEGF
Others
By Dosage Form:
Solid
Liquid
Semisolid
By Disease Indication:
Glaucoma
Dry Eye Disease
Retinal Disease
Allergy & Infections
Others
By Distribution Channel:
Hospital Pharmacies
Retail & Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Ophthalmic Disease Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Ophthalmic Disease Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Ophthalmic Disease Therapeutics Market, by Dosage From, 2019-2029 (USD Billion)
1.2.4. Ophthalmic Disease Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.5. Ophthalmic Disease Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET DYNAMICS
3.1. Ophthalmic Disease Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Ophthalmic Conditions
3.1.1.2. Increasing Clinical Trials and Pipeline Candidates for Innovative Drugs and Therapies
3.1.2. Market Challenges
3.1.2.1. High Cost of Biologics and Overall Treatment Cost
3.1.3. Market Opportunities
3.1.3.1. Rising Technological Advancements in Drug Delivery Options
3.1.3.2. Rising development of personalised medicine
CHAPTER 4. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Ophthalmic Disease Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
6.4.1. Anti-inflammatory
6.4.2. Anti-invectives
6.4.3. Anti-VEGF
6.4.4. Others
CHAPTER 7. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DOSAGE FROM
7.1. Market Snapshot
7.2. Global Ophthalmic Disease Therapeutics Market by Dosage From, Performance - Potential Analysis
7.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Dosage From 2019-2029 (USD Billion)
7.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
7.4.1. Solid
7.4.2. Liquid
7.4.3. Semisolid
CHAPTER 8. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DISEASE INDICATION
8.1. Market Snapshot
8.2. Global Ophthalmic Disease Therapeutics Market by Disease Indication, Performance - Potential Analysis
8.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
8.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
8.4.1. Glaucoma
8.4.2. Dry Eye Disease
8.4.3. Retinal Disease
8.4.4. Allergy & Infections
8.4.5. Others
CHAPTER 9. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
9.1. Market Snapshot
9.2. Global Ophthalmic Disease Therapeutics Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
9.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
9.4.1. Hospital Pharmacies
9.4.2. Retail & Online Pharmacies
CHAPTER 10. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, REGIONAL ANALYSIS
10.1. Ophthalmic Disease Therapeutics Market, Regional Market Snapshot
10.2. North America Ophthalmic Disease Therapeutics Market
10.2.1. U.S. Ophthalmic Disease Therapeutics Market
10.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
10.2.1.2. Dosage From breakdown estimates & forecasts, 2019-2029
10.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2029
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Ophthalmic Disease Therapeutics Market
10.3. Europe Ophthalmic Disease Therapeutics Market Snapshot
10.3.1. U.K. Ophthalmic Disease Therapeutics Market
10.3.2. Germany Ophthalmic Disease Therapeutics Market
10.3.3. France Ophthalmic Disease Therapeutics Market
10.3.4. Spain Ophthalmic Disease Therapeutics Market
10.3.5. Italy Ophthalmic Disease Therapeutics Market
10.3.6. Rest of Europe Ophthalmic Disease Therapeutics Market
10.4. Asia-Pacific Ophthalmic Disease Therapeutics Market Snapshot
10.4.1. China Ophthalmic Disease Therapeutics Market
10.4.2. India Ophthalmic Disease Therapeutics Market
10.4.3. Japan Ophthalmic Disease Therapeutics Market
10.4.4. Australia Ophthalmic Disease Therapeutics Market
10.4.5. South Korea Ophthalmic Disease Therapeutics Market
10.4.6. Rest of Asia Pacific Ophthalmic Disease Therapeutics Market
10.5. Latin America Ophthalmic Disease Therapeutics Market Snapshot
10.5.1. Brazil Ophthalmic Disease Therapeutics Market
10.5.2. Mexico Ophthalmic Disease Therapeutics Market
10.5.3. Rest of Latin America Ophthalmic Disease Therapeutics Market
10.6. Rest of The World Ophthalmic Disease Therapeutics Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Viatris Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Novartis AG
11.2.3. AbbVie Inc.
11.2.4. F. Hoffmann-La Roche Ltd.
11.2.5. Regeneron Pharmaceuticals, Inc.
11.2.6. Santen Pharmaceutical Co., Ltd.
11.2.7. Bayer AG
11.2.8. Bausch & Lomb Incorporated
11.2.9. Merck KGaA
11.2.10. Nicox SA
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Ophthalmic Disease Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Ophthalmic Disease Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Ophthalmic Disease Therapeutics Market, by Dosage From, 2019-2029 (USD Billion)
1.2.4. Ophthalmic Disease Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.5. Ophthalmic Disease Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET DYNAMICS
3.1. Ophthalmic Disease Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Ophthalmic Conditions
3.1.1.2. Increasing Clinical Trials and Pipeline Candidates for Innovative Drugs and Therapies
3.1.2. Market Challenges
3.1.2.1. High Cost of Biologics and Overall Treatment Cost
3.1.3. Market Opportunities
3.1.3.1. Rising Technological Advancements in Drug Delivery Options
3.1.3.2. Rising development of personalised medicine
CHAPTER 4. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Ophthalmic Disease Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
6.4.1. Anti-inflammatory
6.4.2. Anti-invectives
6.4.3. Anti-VEGF
6.4.4. Others
CHAPTER 7. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DOSAGE FROM
7.1. Market Snapshot
7.2. Global Ophthalmic Disease Therapeutics Market by Dosage From, Performance - Potential Analysis
7.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Dosage From 2019-2029 (USD Billion)
7.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
7.4.1. Solid
7.4.2. Liquid
7.4.3. Semisolid
CHAPTER 8. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DISEASE INDICATION
8.1. Market Snapshot
8.2. Global Ophthalmic Disease Therapeutics Market by Disease Indication, Performance - Potential Analysis
8.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
8.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
8.4.1. Glaucoma
8.4.2. Dry Eye Disease
8.4.3. Retinal Disease
8.4.4. Allergy & Infections
8.4.5. Others
CHAPTER 9. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
9.1. Market Snapshot
9.2. Global Ophthalmic Disease Therapeutics Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
9.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
9.4.1. Hospital Pharmacies
9.4.2. Retail & Online Pharmacies
CHAPTER 10. GLOBAL OPHTHALMIC DISEASE THERAPEUTICS MARKET, REGIONAL ANALYSIS
10.1. Ophthalmic Disease Therapeutics Market, Regional Market Snapshot
10.2. North America Ophthalmic Disease Therapeutics Market
10.2.1. U.S. Ophthalmic Disease Therapeutics Market
10.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
10.2.1.2. Dosage From breakdown estimates & forecasts, 2019-2029
10.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2029
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Ophthalmic Disease Therapeutics Market
10.3. Europe Ophthalmic Disease Therapeutics Market Snapshot
10.3.1. U.K. Ophthalmic Disease Therapeutics Market
10.3.2. Germany Ophthalmic Disease Therapeutics Market
10.3.3. France Ophthalmic Disease Therapeutics Market
10.3.4. Spain Ophthalmic Disease Therapeutics Market
10.3.5. Italy Ophthalmic Disease Therapeutics Market
10.3.6. Rest of Europe Ophthalmic Disease Therapeutics Market
10.4. Asia-Pacific Ophthalmic Disease Therapeutics Market Snapshot
10.4.1. China Ophthalmic Disease Therapeutics Market
10.4.2. India Ophthalmic Disease Therapeutics Market
10.4.3. Japan Ophthalmic Disease Therapeutics Market
10.4.4. Australia Ophthalmic Disease Therapeutics Market
10.4.5. South Korea Ophthalmic Disease Therapeutics Market
10.4.6. Rest of Asia Pacific Ophthalmic Disease Therapeutics Market
10.5. Latin America Ophthalmic Disease Therapeutics Market Snapshot
10.5.1. Brazil Ophthalmic Disease Therapeutics Market
10.5.2. Mexico Ophthalmic Disease Therapeutics Market
10.5.3. Rest of Latin America Ophthalmic Disease Therapeutics Market
10.6. Rest of The World Ophthalmic Disease Therapeutics Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Viatris Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Novartis AG
11.2.3. AbbVie Inc.
11.2.4. F. Hoffmann-La Roche Ltd.
11.2.5. Regeneron Pharmaceuticals, Inc.
11.2.6. Santen Pharmaceutical Co., Ltd.
11.2.7. Bayer AG
11.2.8. Bausch & Lomb Incorporated
11.2.9. Merck KGaA
11.2.10. Nicox SA
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Ophthalmic Disease Therapeutics Market, report scope
TABLE 2. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Dosage From 2019-2029 (USD Billion)
TABLE 5. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
TABLE 6. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 7. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Ophthalmic Disease Therapeutics Market
TABLE 72. List of primary sources, used in the study of global Ophthalmic Disease Therapeutics Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Ophthalmic Disease Therapeutics Market, report scope
TABLE 2. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Dosage From 2019-2029 (USD Billion)
TABLE 5. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
TABLE 6. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 7. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Ophthalmic Disease Therapeutics Market
TABLE 72. List of primary sources, used in the study of global Ophthalmic Disease Therapeutics Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Ophthalmic Disease Therapeutics Market, research methodology
FIG 2. Global Ophthalmic Disease Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ophthalmic Disease Therapeutics Market, key trends 2021
FIG 5. Global Ophthalmic Disease Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Ophthalmic Disease Therapeutics Market, porters 5 force model
FIG 7. Global Ophthalmic Disease Therapeutics Market, pest analysis
FIG 8. Global Ophthalmic Disease Therapeutics Market, value chain analysis
FIG 9. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Ophthalmic Disease Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Ophthalmic Disease Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Ophthalmic Disease Therapeutics Market, research methodology
FIG 2. Global Ophthalmic Disease Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ophthalmic Disease Therapeutics Market, key trends 2021
FIG 5. Global Ophthalmic Disease Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Ophthalmic Disease Therapeutics Market, porters 5 force model
FIG 7. Global Ophthalmic Disease Therapeutics Market, pest analysis
FIG 8. Global Ophthalmic Disease Therapeutics Market, value chain analysis
FIG 9. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Ophthalmic Disease Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Ophthalmic Disease Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
